Tag: Pharmaceutical Benefits Scheme


  • Wegovy Moves Closer to PBS Listing for Adults with Obesity and Heart Disease

    Wegovy Moves Closer to PBS Listing for Adults with Obesity and Heart Disease

    What is Wegovy and why the PBS listing matters Semaglutide, marketed as Wegovy, is a prescription medication designed to help adults with obesity lose weight and improve related health risks. The latest development from the Pharmaceutical Benefits Advisory Committee (PBAC) signals a significant step toward adding Wegovy to the Pharmaceutical Benefits Scheme (PBS) for people…

  • Wegovy Advances to PBS Listing: Semaglutide for Obesity and Heart Disease

    Wegovy Advances to PBS Listing: Semaglutide for Obesity and Heart Disease

    Wegovy Moves Closer to PBS Listing Semaglutide, sold under the brand Wegovy, is nearing a pivotal milestone in Australia’s healthcare system. After preliminary recommendations from the Pharmaceutical Benefits Advisory Committee (PBAC), Wegovy could soon be available on the Pharmaceutical Benefits Scheme (PBS) for adults with established cardiovascular disease who also have obesity. This potential PBS…

  • Wegovy Moves Closer to PBS Listing for Australians with Obesity and Heart Risk

    Wegovy Moves Closer to PBS Listing for Australians with Obesity and Heart Risk

    What’s happening with Wegovy and the PBS The anti-obesity drug Wegovy, whose active ingredient is semaglutide, has taken a significant step toward being added to Australia’s Pharmaceutical Benefits Scheme (PBS). The move signals a potential change in how adults living with obesity and established cardiovascular disease could access a proven therapy at a reduced price,…

  • Cheaper Cancer and Chronic Condition Medicines Join Australia’s PBS List

    Cheaper Cancer and Chronic Condition Medicines Join Australia’s PBS List

    New PBS Listings Expand Access to Life-Saving Treatments A wave of relief is sweeping across Australia’s healthcare system as cheaper cancer and chronic condition medicines become available to more patients through the Pharmaceutical Benefits Scheme (PBS). The latest PBS listings and price reductions are designed to ease the financial burden on families while ensuring that…

  • Cheaper Cancer and Chronic Condition Medicines Now on PBS: A Vital Step for Australian Patients

    Cheaper Cancer and Chronic Condition Medicines Now on PBS: A Vital Step for Australian Patients

    New PBS Listings Bring Cheaper Treatments for Cancer and Chronic Conditions Australian patients battling cancer and chronic conditions can breathe easier as a series of new and expanded medicines have been listed on the Pharmaceutical Benefits Scheme (PBS). This move is designed to reduce out-of-pocket costs for families and improve access to life-changing therapies that…

  • Cheaper Cancer And Chronic Conditions Medicines Now On PBS

    Cheaper Cancer And Chronic Conditions Medicines Now On PBS

    Australia Expands Access to Essential Medicines Through the PBS Australians living with cancer and chronic conditions will benefit from a new listing on the Pharmaceutical Benefits Scheme (PBS), a government program designed to make critical medicines more affordable. The latest announcement signals a practical step toward reducing out-of-pocket costs for patients who rely on life-changing…